Crew-12's mission ends, and NASA tallies the science
The four astronauts of NASA's SpaceX Crew-12 are preparing to leave the International Space Station, and before they do, the agency has published a wrap-up of the science they completed in orbit. The summary, released by NASA's International Space Station Research Communications Team on October 2, 2026, lists research spanning pharmaceutical crystals, quantum physics, bone regeneration, antibiotic-resistant bacteria, cartilage tissue, metal printing, intravenous fluids and stem cells.
The crew consists of NASA astronauts Jessica Meir and Jack Hathaway, ESA (European Space Agency) astronaut Sophie Adenot, and Roscosmos cosmonaut Andrey Fedyaev. NASA states they are scheduled to return in early October 2026 aboard their SpaceX Dragon spacecraft. The team launched to the station on February 13, 2026, and docked the following day, according to NASA image catalog records.
For readers who do not follow spaceflight closely, the point of this list is not the spacecraft. It is the laboratory. The space station's defining feature, continuous weightlessness, is not available on Earth, and several of these experiments cannot be run anywhere else. This article walks through four of the mission's research lines and what each one could mean for people on the ground, keeping claims tied to what NASA has actually stated and flagging what remains unproven.
Why weightlessness matters to a chemist
A common assumption is that orbit is simply a dramatic backdrop for routine lab work. NASA's own framing pushes back on that. In the mission summary, the agency describes microgravity as a way to "experiment through a new perspective", noting that in space researchers can observe changes in how cells behave and how materials take shape.
The reason is physical, not poetic. On Earth, buoyancy-driven convection stirs fluids and sedimentation pulls particles downward, effects that interfere with some precision measurements. In microgravity, those forces largely disappear. Crystals can grow more evenly, particles can assemble differently, and cells can organize into structures that resemble how they behave inside the body more closely than a dish on a lab bench does.
None of that guarantees results. Each investigation below is a test run aboard the station, and most of its findings still need ground-based follow-up, clinical trials and, in several cases, years of engineering before any patient benefit exists. What the mission has already produced is data and samples, gathered under conditions no terrestrial lab can replicate.
Cancer-treatment crystals grown in orbit
Jack Hathaway was photographed floating alongside hardware used for crystal growth experiments. According to NASA, microgravity reveals new details about crystal structures that help researchers improve the quality and stability of pharmaceuticals, and in this case cancer-targeting treatments are crystallized in orbit to better understand their properties. NASA identifies the investigation as the Pharmaceutical In-space Laboratory, or ADSEP-PIL-15.
Why does a crystal grown in weightlessness matter for medicine? Many modern drugs are delivered as crystalline solids, and the arrangement, size and uniformity of those crystals affect how stable and how well-absorbed a drug is. A poorly formed crystal can degrade faster or dissolve unpredictably. Growing crystals without the sedimentation and convection found on Earth can produce more orderly structures, giving researchers a clearer picture of what an ideal drug formulation looks like.
This is work in progress, not a finished therapy. NASA's page says the orbital crystals are studied to help advance cancer therapies on Earth, which is a research goal rather than a verified clinical outcome. But the mechanism is concrete: better crystal data now, potentially better drug manufacturing and quality control later.
A wooden scaffold against bone loss
ESA astronaut Sophie Adenot handled one of the mission's most directly medical investigations: a bone scaffold made from wood, designed to mimic the structure of real bones and support the growth of bone cells. NASA calls the study Green Bone, and its stated logic is elegant. Because microgravity accelerates bone loss, the station itself acts as an accelerated model of osteoporosis, letting researchers test how well the scaffold promotes bone regeneration in a compressed time frame.
The human stakes are large. NASA's summary notes that osteoporosis affects more than 200 million people globally. If a wood-derived scaffold can be shown to support bone regeneration effectively, the research could inform future treatments for those patients, as well as protecting astronauts on long missions.
It is worth being precise about what has and has not happened. What has happened is that the scaffold was tested in orbit against accelerated bone loss. What has not happened, so far as the NASA page states, is a proven therapy. The agency describes the insights as potentially providing new treatment options, which is a prediction grounded in early results, not an established one.
Making IV fluids and metal parts where you are
Two of the mission's lines of work sound like logistics but carry real medical weight. The first is IV fluid generation. NASA reports that Adenot worked to produce intravenous fluid on demand in microgravity, under the Intravenous Fluid Generation Mini (IVGEN Mini) investigation. The agency states that commercial IV fluids expire after about 16 months, and that carrying them on long-duration missions adds weight and takes up valuable space.
That shelf-life constraint sounds like a niche spaceflight problem, but it is not. Intravenous fluids are among the most basic tools of hospital and emergency care anywhere on Earth, and the same expiry limits apply in rural clinics, disaster zones and military field hospitals. NASA explicitly frames the potential payoff this way: a system that produces IV fluid from local resources could provide a critical medical resource when resupply is limited and improve access in remote areas or during emergencies on Earth.
The second line is manufacturing. NASA reports that Adenot installed the Metal 3D Printer aboard the station, and that several small metal parts have already been printed in microgravity and returned to Earth, where their quality is being evaluated against parts made on the ground. The near-term goal for deep-space missions is clear: future crews far from Earth could make or replace what they need rather than waiting for a resupply rocket. The Earth-facing echo is more modest but real: every demonstration of reliable on-demand manufacturing in extreme conditions is also a demonstration of what remote manufacturing could become.
Cartilage, stem cells and bone marrow in a dish
Jessica Meir led several investigations with a forward-looking medical flavor. According to NASA, she worked on BEM-CARTS, a study of how engineered cartilage tissue develops in microgravity, which may help scientists produce medical implants that more closely resemble natural cartilage. The agency notes that for millions of people with cartilage injuries, space-grown tissue could offer treatment options that do not require transplanting cartilage from another part of the body.
Meir also conducted a stem cell investigation under InSPA-StemCellEX-H2. NASA states that microgravity can help produce larger numbers of clinical-grade stem cells that retain their ability to transform into other cells, and that cells used in this experiment could help rebuild blood and immune systems after chemotherapy, advancing care for leukemia and other blood diseases on Earth.
A third investigation, the 3D Bone Marrow Analog, was handled by Hathaway and uses bone marrow cells to study how microgravity affects bone and muscle. NASA says the research uses structures that mimic parts of bone marrow, and some samples were exposed to vibrations simulating exercise, with the aim of finding new ways to combat bone and muscle loss during spaceflight and support bone health on Earth.
For all three, the same caution applies. These are experiments run aboard the station, and NASA's language reflects that: cells could help, implants may be produced, research could reveal new ways. The station is a discovery platform, not a clinic. The patients who would benefit from any of this work are, for now, waiting on the results of science that is still in its early chapters.
Beyond medicine: quantum atoms, resistant bacteria and the view from orbit
Not every investigation aimed at a hospital. Meir worked with cables that deliver light used to cool, trap and study atoms inside the Cold Atom Lab, NASA's orbital quantum physics facility. The agency explains that in microgravity, ultracold atoms can be observed for longer periods, giving scientists a longer window into quantum behavior, and that a recent upgrade increases the number of atoms produced. NASA says the resulting data supports quantum technologies such as solar cells and the components that power cell phones and computers.
Hathaway, meanwhile, held equipment for testing antibiotic-resistant bacteria aboard the station, under the GEARS investigation (Genomic Enumeration of Antibiotic Resistance in Space). NASA notes that some bacteria can withstand antibiotics, starvation and disinfection, a concern in closed environments like spacecraft, and that sequencing DNA in microgravity can reveal how resilient microbes adapt, informing countermeasures for exploration missions and efforts to combat resistance on Earth.
The crew's science also depended on logistics. NASA's summary notes that the Northrop Grumman Commercial Resupply Services 24 mission delivered fresh produce and new research, including an instrument that could improve space-weather modeling and a project aimed at protecting gut-microbiome stability on future missions.
Finally, the mission summary also highlights a simpler kind of value: the view. NASA notes that the crew looked out the window of a Dragon spacecraft during their journey to the station, a destination that offers a unique vantage point on both Earth and the cosmos. The station's research value starts with perspective, and this mission's report is a snapshot of what four people did with it.
One sourcing limitation should be stated plainly: the primary evidence for this article is NASA's own mission summary page and NASA image catalog records, both retrieved October 3, 2026. No independent peer-reviewed results for these investigations have been assessed here, and several experiment names link to NASA research-explorer pages whose detailed results were not separately verified for this article. NASA's own descriptions of expected benefits are predictions, not findings.